Mayo Clinic proceedings
Audio Summaries

Gut Oxalate Transport and Gut Microbiome as Potential Therapeutic Targets for Hyperoxaluria and Hyperoxalemia: Implications for Related Human Disease

May 8, 2026

The authors investigate the potential of targeting gut oxalate transport and the gut microbiome as therapeutic strategies for managing hyperoxaluria and hyperoxalemia, conditions linked to kidney stones and chronic kidney disease. They highlight the role of the gut in oxalate homeostasis and the importance of oxalate-degrading bacteria in reducing oxalate absorption, while noting that most current evidence is based on animal studies, leaving a gap in understanding its relevance to human health.

Hybrid Quantum-Classical Model That Combines Spatial-Temporal EEG and Digitized Counterdiabatic Quantum Features for Motor Imagery Classification

May 7, 2026

The authors aimed to develop a quantum-feature enhanced algorithm for classifying motor imagery (MI) using electroencephalogram (EEG) data. By integrating a spatial-temporal deep learning architecture with digitized counterdiabatic quantum features, they achieved high classification accuracy of 88.8% in an external evaluation and 89.8% across a larger dataset, suggesting that this hybrid approach could significantly advance the application of quantum computing in healthcare.

Resting Heart Rate is an Independent Prognostic Marker for Cancer Mortality and a Modifiable Target of Physical Activity: A Prospective Cohort Study From 615,730 Asian Participants

May 2, 2026

The authors aimed to investigate the independent and combined effects of resting heart rate (RHR) and physical activity (PA) on cancer mortality in a large cohort of cancer-free Taiwanese adults. They found that elevated RHR is a significant predictor of increased cancer mortality, and engaging in regular physical activity can substantially reduce this risk, particularly in individuals with higher initial RHR levels. The study suggests that RHR could serve as a practical marker for encouraging physical activity as a means of cancer prevention.

Consensus Recommendation: Real World Insights on Attitudes and Treatment of Hyperkalemia

May 2, 2026

The authors aimed to identify barriers to guideline-directed medical therapy (GDMT) for hyperkalemia and explore real-world solutions to improve patient management. Through a panel discussion involving nephrology experts, they reviewed the epidemiology of hyperkalemia, current treatment guidelines, and management pathways, ultimately concluding that prescriptive protocols and potassium-restrictive diets are inadequate treatment strategies. The findings highlight the need for enhanced education and alternative approaches to optimize care for patients with hyperkalemia.

Heart Failure Phenotypes and the Prognostic Utility of NT-proBNP in Patients With Chronic Kidney Disease: A Propensity-Score Matched Cohort Study

May 1, 2026

The authors aimed to assess the prognostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in predicting outcomes across different heart failure phenotypes in patients with chronic kidney disease (CKD). The study found that patients with heart failure with reduced ejection fraction (HFrEF) had higher NT-proBNP levels and an increased risk of all-cause mortality and major adverse cardiac events compared to those with heart failure with preserved ejection fraction (HFpEF), while NT-proBNP's predictive value for renal outcomes was limited.

On the Spectrum: High-Functioning Autism and Its Contemporary Relevance

May 1, 2026

The authors examine the contemporary relevance of high-functioning autism, particularly in light of the DSM-5's reclassification of autism spectrum disorder, which has led to a significant increase in diagnosed cases. They aim to address the challenges faced by adults with high-functioning autism, including social and occupational difficulties, and emphasize the importance of recognizing and managing comorbid conditions while providing appropriate support services to enhance quality of life.

Exploring the Promise of Improvisational Theatre Applications in Health Care: A Scoping Review

Apr 29, 2026

The authors aimed to investigate the design, implementation challenges, and benefits of applied improvisational theatre programs in health care settings for various participant groups. Through a scoping review of 694 sources, they found that these programs often focus on enhancing communication, teamwork, and empathy, with a growing emphasis on supporting patients and caregivers, particularly in dementia care. The findings suggest that improvisational techniques have become a valuable tool for experiential learning in health care.

Traditional Risk Factors Provide Limited Insight Into Long-Term Cardiovascular Risk After Carotid Endarterectomy

Apr 24, 2026

The authors aimed to determine the incidence of major adverse cardiovascular events (MACE) and identify long-term clinical predictors in patients with carotid artery disease following carotid endarterectomy (CEA). They found that traditional risk factors provided limited insight into the high incidence of MACE, highlighting the need for novel approaches to improve risk assessment and guide secondary prevention strategies in this patient population.

Acute Estimated Glomerular Filtration Rate Decline After Initiation of Therapies That Slow Kidney Disease Progression: Clinical Practice Implications

Apr 22, 2026

The authors investigate the implications of an acute decline in estimated glomerular filtration rate (eGFR) following the initiation of therapies aimed at slowing chronic kidney disease (CKD) progression in patients with type 2 diabetes. They find that while these therapies may cause an initial eGFR decline, this is typically reversible and linked to beneficial hemodynamic changes, suggesting that such declines should not deter treatment continuation. The review emphasizes that an acute eGFR decline of less than 30% is generally not indicative of adverse kidney effects and may even predict better long-term outcomes.

Association of GLP-1 Receptor Agonist Use With Chronic Kidney Disease Risk in Type 2 Diabetes: Multicenter Emulated Target Trials

Apr 21, 2026

The authors aimed to determine whether the initiation of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduced risk of chronic kidney disease (CKD) compared to dipeptidyl peptidase-4 inhibitors (DPP-4is) in patients with type 2 diabetes (T2D) who do not have pre-existing CKD. Their findings indicate that GLP-1 RA users experienced significantly lower risks of composite kidney outcomes, incident CKD, acute kidney injury, major adverse cardiac events, and all-cause mortality compared to those using DPP-4is.